Literature DB >> 26947081

Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.

Stephanie Grabow1, Alex R D Delbridge2, Brandon J Aubrey3, Cassandra J Vandenberg2, Andreas Strasser4.   

Abstract

MCL-1 is critical for progenitor cell survival during emergency hematopoiesis, but its role in sustaining cells undergoing transformation and in lymphomagenesis is only poorly understood. We investigated the importance of MCL-1 in the survival of B lymphoid progenitors undergoing MYC-driven transformation and its functional interactions with pro-apoptotic BIM and PUMA and the tumor suppressor p53 in lymphoma development. Loss of one Mcl-1 allele almost abrogated MYC-driven-lymphoma development owing to a reduction in lymphoma initiating pre-B cells. Although loss of the p53 target PUMA had minor impact, loss of one p53 allele substantially accelerated lymphoma development when MCL-1 was limiting, most likely because p53 loss also causes defects in non-apoptotic tumor suppressive processes. Remarkably, loss of BIM restored the survival of lymphoma initiating cells and rate of tumor development. Thus, MCL-1 has a major role in lymphoma initiating pro-B cells to oppose BIM, which is upregulated in response to oncogenic stress.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BIM; MCL-1; MYC; apoptosis; lymphoma; p53

Mesh:

Substances:

Year:  2016        PMID: 26947081     DOI: 10.1016/j.celrep.2016.02.039

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  22 in total

1.  The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice.

Authors:  Kerstin Brinkmann; Stephanie Grabow; Craig D Hyland; Charis E Teh; Warren S Alexander; Marco J Herold; Andreas Strasser
Journal:  Cell Death Differ       Date:  2017-08-11       Impact factor: 15.828

2.  BCL-W has a fundamental role in B cell survival and lymphomagenesis.

Authors:  Clare M Adams; Annette S Kim; Ramkrishna Mitra; John K Choi; Jerald Z Gong; Christine M Eischen
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

Review 3.  Survival control of malignant lymphocytes by anti-apoptotic MCL-1.

Authors:  Y Fernández-Marrero; S Spinner; T Kaufmann; P J Jost
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

4.  Loss of TRP53 reduces but does not overcome dependency of lymphoma cells on MCL-1.

Authors:  Andreas Strasser; Gemma L Kelly; Brandon J Aubrey; Margs S Brennan; Sarah T Diepstraten; Zilu Wang; Catherine Chang; Marco J Herold
Journal:  Cell Death Differ       Date:  2022-01-28       Impact factor: 12.067

5.  Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.

Authors:  Hai Vu Nguyen; Cassandra J Vandenberg; Ashley P Ng; Mikara R Robati; Natasha S Anstee; Joel Rimes; Edwin D Hawkins; Suzanne Cory
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

Review 6.  Targeting MCL-1 in hematologic malignancies: Rationale and progress.

Authors:  Andrew H Wei; Andrew W Roberts; Andrew Spencer; Aaron Seth Rosenberg; David Siegel; Roland B Walter; Sean Caenepeel; Paul Hughes; Zach McIver; Khalid Mezzi; Phuong Khanh Morrow; Anthony Stein
Journal:  Blood Rev       Date:  2020-02-21       Impact factor: 8.250

7.  Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.

Authors:  Ana Domostegui; Suresh Peddigari; Carol A Mercer; Flavia Iannizzotto; Marta L Rodriguez; Marta Garcia-Cajide; Virginia Amador; Sarah T Diepstraten; Gemma L Kelly; Ramón Salazar; Sara C Kozma; Eric P Kusnadi; Jian Kang; Antonio Gentilella; Richard B Pearson; George Thomas; Joffrey Pelletier
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476

8.  BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells.

Authors:  Adam G Southon; Eiman Saleh; Diane Moujalled; Kerstin Brinkmann; Francine Ke; Melinda Iliopoulos; Ryan S Cross; Misty R Jenkins; Duong Nhu; Zilu Wang; Melissa X Shi; Ruth M Kluck; Guillaume Lessene; Stephanie Grabow; Ashley I Bush; Andreas Strasser
Journal:  Cell Death Differ       Date:  2022-03-24       Impact factor: 12.067

9.  Dynein light chain 1 induces assembly of large Bim complexes on mitochondria that stabilize Mcl-1 and regulate apoptosis.

Authors:  Prafull Kumar Singh; Aristomenis Roukounakis; Daniel O Frank; Susanne Kirschnek; Kushal Kumar Das; Simon Neumann; Josef Madl; Winfried Römer; Carina Zorzin; Christoph Borner; Aladin Haimovici; Ana Garcia-Saez; Arnim Weber; Georg Häcker
Journal:  Genes Dev       Date:  2017-09-01       Impact factor: 11.361

Review 10.  The Quest for Targets Executing MYC-Dependent Cell Transformation.

Authors:  Markus Hartl
Journal:  Front Oncol       Date:  2016-06-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.